DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 51 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,080,000 | +10.6% | 200,000 | -20.0% | 0.01% | -7.1% |
| Q1 2020 | $4,593,000 | -47.9% | 250,000 | -37.5% | 0.01% | -36.4% |
| Q4 2019 | $8,812,000 | -75.9% | 400,000 | -84.3% | 0.02% | -75.6% |
| Q3 2019 | $36,618,000 | -17.0% | 2,550,000 | -8.9% | 0.09% | -18.2% |
| Q2 2019 | $44,100,000 | -1.3% | 2,800,000 | -8.2% | 0.11% | -1.8% |
| Q1 2019 | $44,683,000 | +37.0% | 3,050,000 | 0.0% | 0.11% | +24.4% |
| Q4 2018 | $32,605,000 | -12.8% | 3,050,000 | +24.5% | 0.09% | +8.4% |
| Q3 2018 | $37,387,000 | +24.6% | 2,450,000 | 0.0% | 0.08% | +20.3% |
| Q2 2018 | $30,013,000 | +82.0% | 2,450,000 | +42.0% | 0.07% | +81.6% |
| Q1 2018 | $16,491,000 | -7.5% | 1,725,000 | -12.7% | 0.04% | -5.0% |
| Q4 2017 | $17,834,000 | – | 1,975,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |